Stockholm’s Pixelgen Technologies secures €13.26 million to advance spatial mapping of cell-surface proteins
Sintesi DuoBiz · · 2 min di lettura
Di cosa si tratta
Pixelgen Technologies, a Stockholm-based life sciences company that claims to have developed the first high-throughput platform for mapping molecular cell architecture, has closed an oversubscribed €13.26 million ($15.5 million) Series B funding round. The round was led by new investor Flat Capital, with continued participation from existing investors Industrifonden and Navigare Ventures. Alongside the financing, […] The post Stockholm’s Pixelgen Technologies secures €13.26 million to advance spatial mapping of cell-surface proteins appeared first on EU-Startups .
Fonte: EU-Startups
